Results 81 to 90 of about 17,391 (234)

A Comprehensive Review of Interstitial Lung Abnormalities

Respirology, EarlyView.
ABSTRACT Interstitial lung abnormalities (ILAs) represent radiological entities that comprise changes compatible with an interstitial process, occurring in individuals not suspected to have interstitial lung disease (ILD). The prevalence of ILAs ranges from 2.5% to 16.7% in lung cancer screening and population‐based cohorts. ILAs have consistently been
Yuben Moodley, John A. Mackintosh
wiley   +1 more source

Comparison of Three Methods of Predictive Postoperative FEV1 and DLCO Calculations in Relation to Their Observed Postoperative Values in Lung Resection [PDF]

, 2020
Vjekoslav Karadža, Ivanka Karadža
openalex   +1 more source

Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti‐Fibrotic Treatment: Real‐World Data From the Dutch National Registry

Respirology, EarlyView.
ABSTRACT Background and Objective Real‐world data on lung function course of patients with progressive pulmonary fibrosis (PPF) treated with anti‐fibrotic medication are limited. We evaluated forced vital capacity (FVC) decline in patients with PPF and idiopathic pulmonary fibrosis (IPF) who started anti‐fibrotic treatment.
Mark G. J. P. Platenburg, Gizal Nakshbandi, Catharina C. Moor, Aernoud A. van Batenburg, Rémy L. M. Mostard, Mareye Voortman, Linda A.A. Moonen, Nicolle Hekelaar, Maria J. Overbeek, Brigitte A.H.A. Bogaarts, Henk Kramer, Emiel. R. Marges, Bart B. Boerrigter, Paul Bresser, Eveline L. Schakenraad, Jan van der Maten, Niels C.A. van der Sloot, Stefan Walen, Pedro Miranda Afonso, Marlies S. Wijsenbeek, Jan C. Grutters   +20 more
wiley   +1 more source

Impact of A Multidisciplinary Team Discussion for Genetic Lung Fibrosis

Respirology, EarlyView.
ABSTRACT Background and Objective Approximately 30% of individuals diagnosed with familial pulmonary fibrosis (FPF) exhibit a pathogenic variant upon genetic analysis. We established a genetic Multidisciplinary Discussion (geneMDD) aimed to enhance expertise in diagnosing and managing FPF.
Giovanni Franco, Ibrahima Ba, Nadia Nathan, Cécile Guerin, Albane Lassus, Caroline Kannengiesser, Antoine Froidure, Effrosyni Manali, Vincent Bunel, Philippe Bonniaud, Diane Bouvry, Marie Pierre Debray, Pierre Antoine Juge, Ralph Epaud, Camille Louvrier, Aurélie Plessier, Flore Sicre de Fontbrune, Lidwine Wémeau‐Stervinou, Sylvain Marchand Adam, Alexandre Chabrol, Arnaud Maurac, Laurent Savale, David Montani, Caroline Raynal, Marina Konyukh, Arthur Mageau, Bruno Crestani, Vincent Cottin, Alix de Becdelièvre, Raphaël Borie, Respifil and OrphaLung   +30 more
wiley   +1 more source

Nutritional status and airflow obstruction: two independent contributors to CO diffusing capacity impairment in COPD

Monaldi Archives for Chest Disease, 2005
Background. The association between weight loss and Chronic Obstructive Pulmonary Disease (COPD) has been recognised from many years. Based on the evidence that nutritional status reflects metabolic disturbances in COPD, the relationship between body ...
S. Baldi, G.D. Pinna, P. Crotti, S. Montemartini, E. Dacosto, F. Fanfulla, C. Fracchia, C. Bruschi   +7 more
doaj   +1 more source

DLCO and exercise intolerance_Online supplement_JAP_July 16 2019.docx

, 2019
This is a file containing online data supplement for a manuscript submitted to JAP. It contains text, 2 tables and 3 figures.
Amany Elbehairy, O'Donnell, Conor D, Elhameed, Asmaa Abdel Abd, Vincent, Sandra G, Milne, Kathryn M., James, Matthew D, Webb, Katherine A., J. Alberto Neder, O'Donnell, Denis E   +8 more
openaire   +1 more source

Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis

Respirology, EarlyView.
ABSTRACT Background and Objective Idiopathic pulmonary fibrosis is a progressive interstitial lung disease characterised by excessive activation of myofibroblasts. However, currently available antifibrotic drugs exhibit limited efficacy. The dysregulation of redox processes plays a significant role in the pathogenesis of idiopathic pulmonary fibrosis ...
Jie Huang, Nana Liu, Yueyue Jin, Shuangyu Han, Lian Li, Yunze Du, Luqing Wei, Dongsheng Li, Yan Zhang, Yubao Wang, Jau‐Shyong Hong, Wen Ning, Jing Feng   +12 more
wiley   +1 more source

Born high, born fast: Does highland birth confer a pulmonary advantage for sea level endurance?

Experimental Physiology, EarlyView.
Abstract Less than 7% of the world's population live at an altitude above 1500 m. Yet, as many as 67% of medalists in the 2020 men's and women's Olympic marathon, and 100% of medalists in the 2020 men's and women's Olympic 5000 m track race may have been born or raised above this otherwise rare threshold.
Hunter L. Paris, Marissa N. Baranauskas, Keren Constantini, Ren‐Jay Shei, Peyton E. Allen, John R. Jadovitz, Chad C. Wiggins, Cooker Perkins Storm   +7 more
wiley   +1 more source

DIFFUSION LUNG CAPACITY FOR CARBON MONOXIDE (DLCO) IS AN INDEPENDENT PREDICTOR FOR LONG-TERM SURVIVAL AFTER CURATIVE LUNG RESECTION FOR LUNG CANCER [PDF]

, 2008
Jun Li, Sanjib Basu, Michael C. Hoaglin, Neil Freedman, L. Penfield Faber, William H. Warren, Zane T. Hammoud, Anthony W. Kim   +7 more
openalex   +1 more source

Nocturnal pulse oxygen saturation dynamics at simulated high altitude: Predictive value for acute mountain sickness in healthy men born pre‐term

Experimental Physiology, EarlyView.
Abstract The physiological sequelae of pre‐term birth might influence the responses of this population to hypoxia. Moreover, identifying variables associated with development of acute mountain sickness (AMS) remains a key practically significant area of altitude research.
Benjamin J. Narang, Giorgio Manferdelli, Grégoire P. Millet, Tadej Debevec   +3 more
wiley   +1 more source